Featured DVC Press Release
CSC's DynPort Vaccine Company Releases Results for Phase 2 Botulinum Vaccine Clinical Trial
FALLS CHURCH, Va., Jan. 24, 2012 – CSC (NYSE: CSC) announced today that DynPort Vaccine Company LLC (DVC), a CSC company, has completed a Phase 2 clinical trial for its recombinant botulinum vaccine candidate, rBV A/B.
In the News
DVC Hosts Winter Coat Drive
During the month of December, DVC employees donated 38 gently used winter coats to the local rescue mission.
DVC Named to Frederick's Best Places to Work 2011
In an October 18, 2011 awards ceremony at the Delaplaine Visual Arts Education Center, DVC took top honors in the large employer category for businesses with 50-200 employees.
DVC President Dr. Robert V. House Comments on Biotech Industry
"Biotechnology is one of the few things in the world we're leading the world in," said House at a recent biotech event hosted by the Frederick Chamber of Commerce.
Featured CSC News
DVC is a wholly owned CSC subsidiary. Visit the CSC newsroom for more CSC news.
CSC Recognized as a Top Military-Friendly Employer
FALLS CHURCH, Va., Nov. 14 – CSC (NYSE: CSC) announced today that it has received two significant awards for the employment of veterans and military spouses. The company was recognized by G.I. Jobs magazine as one of America’s “Top 100 Military Friendly Employers,” and by Military Spouse magazine as a “Top 20 Military Spouse Friendly Employer.”
Report: Should Healthcare Organizations Use Social Media?
Healthcare organizations are using social media as an important tool to connect consumers and providers. Early adopters show that social media can be used to influence customers and accomplish strategic healthcare goals.
CSC Recognized as a Top Corporate Citizen by CR Magazine
FALLS CHURCH, Va., Oct. 27 – CSC (NYSE: CSC) announced today that it has been ranked in the top ten by Corporate Responsibility (CR) Magazine as one of the “Industry Sector Best Corporate Citizens in Business Services” for 2011.
Corporate Responsibility
CSC's third corporate responsibility report highlights our significant accomplishments for 2010-2011. Our efforts focus on our employees, on client trust and partner collaboration, environmental sustainability, community engagement and ethical governance. View the interactive report.
We are pleased to have made considerable progress this year toward integrating corporate responsibility into our culture and business. Our efforts are laying the groundwork for future company growth, client loyalty and global sustainability.
Opinion
DVC President Dr. Robert V. House discusses news and issues related to biopharmaceutical product development and biological defense in his Bugs and Drugs Blog. Leave a comment and join the conversation!
About DVC
Media Information
Media Contact
Press inquiries ONLY:
April Finnen
+1 301.607.5004
>email
If you are not a reporter, please use this form to contact us, for the quickest response. (We promise it goes right to a real person--a few actually.)
April Finnen
+1 301.607.5004